Ekso Bionics Holdings (EKSO) Share-based Compensation (2016 - 2026)
Ekso Bionics Holdings has reported Share-based Compensation over the past 13 years, most recently at $783000.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation rose 155.05% to $783000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 7.28% increase, with the full-year FY2025 number at $1.5 million, up 7.36% from a year prior.
- Share-based Compensation reached $783000.0 in Q4 2025 per EKSO's latest filing, up from $234000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $928000.0 in Q4 2022, with the low at $207000.0 in Q2 2025.
- The 5-year median for Share-based Compensation is $460000.0 (2023), against an average of $479050.0.
- Peak YoY movement for Share-based Compensation: crashed 48.38% in 2023, then soared 155.05% in 2025.
- Tracing EKSO's Share-based Compensation over 5 years: stood at $791000.0 in 2021, then grew by 17.32% to $928000.0 in 2022, then crashed by 48.38% to $479000.0 in 2023, then plummeted by 35.91% to $307000.0 in 2024, then surged by 155.05% to $783000.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods came in at $783000.0, $234000.0, and $207000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.